It has been suggested that elevated levels of insulin or insulinlike growth factors (IGFs) play a role in the development of diabetic vascular complications. Previously, we have shown a differential response to insulin between vascular cells from retinal capillaries and large arteries with the former being much more insulin responsive. In the present study, we have characterized the receptors and the growth-promoting effect of insulinlike growth factor I (IGF-I) and multiplication-stimulating activity (MSA, an IGF-II) on endothelial cells and pericytes from calf retinal capillaries and on endothelial and smooth muscle cells from calf aorta.
Introduction
Proliferative retinopathy is one of the most common and serious vascular complications of diabetes, leading to blindness in 50% of patients within 5 yr (1). The major pathological finding in the eye is neovascularization, which is the proliferation of retinal capillary endothelial cells (2) . The factors that are responsible for neovascularization are not known, but growth hormone and its proposed mediators, the somatomedins, have been suggested to play a role (3, 4) . Growth hormonedeficient dwarfs have glucose intolerance, but do not develop retinopathy (5) , and severe proliferative retinopathy appears to be ameliorated in some patients by pituitary ablation (3) . Recently, Lamberton et al. also reported that one of the somatomedins, insulinlike growth factor I (IGF-I),' is elevated in some diabetic patients with advanced proliferative retinopathy (4), although the IGFs are not increased in diabetic patients with proliferative retinopathy as a whole (6) .
Even though tissues involved in diabetic complications have generally been regarded as nonhormonally dependent, we recently demonstrated that endothelial cells and supporting cells of both large and small blood vessels possess insulin receptors and are insulin responsive (7) . In the present study, we have characterized the receptors of IGF-I and multiplicationstimulating activity (MSA, a rat IGF-II) and growth-promoting effects of these growth factors in addition to growth hormone on cultured endothelial cells from bovine retinal capillaries and aorta, and on the supporting cells of these vessels; namely, the retinal capillary pericytes and aortic smooth muscle cells. We have also compared the effect of these hormones to those of insulin in the same tissues.
Methods
Porcine insulin was purchased from Elanco Products Co., Indianapolis, IN. Pure IGF-I, isolated from human plasma by procedures as described previously, was a generous gift of Professor Rene E. Humbel (Biochemisches Institut der UniversitAt, Zurich, Switzerland) (8) . MSA was purified from conditioned media harvested from cultured cell lines of Buffalo rat liver cells, as previously described (9) . Bovine growth hormone was kindly provided by Dr. Leo Reichert at the National Institutes of Health (NIH GH B18). Nal25I was obtained from New England Nuclear, Boston, MA. All other chemicals were of analytical grade and obtained from the Sigma Chemical Co., St. Louis, MO.
Iodination. Porcine insulin was iodinated by the lactoperoxidase method and the four monoiodoisomers were separated by high performance liquid chromatography on a reverse-phase column, as described previously (10) . The isomer labeled on the 14 tyrosyl residue of the A chain of the insulin molecule (specific activity of 360 zCi/ug) was used as the tracer in all subsequent studies. Previous studies have shown that this isomer is indistinguishable from native insulin in its affinity for the insulin receptor and its bioactivity (1 1).
Both IGF-I and MSA III-2 were labeled by the modified chloramine T method and separated away from 1251I and aggregated IGFs on a G-50 column (12) . The specific radioactivity of both the 1251I-IGF-I and '251I-MSA used for the present studies ranged from 50 to 150 ,Ci/ug.
Cell cultures. Retinal capillary endothelial cells and pericytes were harvested from calf retinal capillaries, as described previously (7, 12 (12) . For pericytes, "conditioned" DMEM with 20% calf serum was used. The sarcoma conditioned media was used because it promotes the growth of retinal endothelial cells.
2-3 d after plating, either the endothelial or support cells were identified under a phase-contrast microscope and the unwanted cell type as defined by morphology was removed using a finely tapered Pasteur pipette attached to a micromanipulator (Brinkmann Instruments, Inc., Westbury, NY) as described by Folkman et al. (13) . This "weeding" procedure was performed daily until pure cultures were obtained. The cells were then harvested by treatment with 1 ml of 0.05% trypsin (Sigma Chemical Co.), with 0.2% EDTA (Gibco Laboratories) for 3 min.
Calf aortic endothelial cells were isolated as described previously (7) . Briefly, the intimal aspect of calf aorta was exposed and incubated in 0.1% collagenase (Worthington Biochemical Corp.) for 30 Aortic smooth muscle cells were harvested from calf aorta using a modification of the procedures as Gimbrone et al. (14) . The cells were initially removed from the medial section of the aorta by dissection.
The explants were set in a Costar culture dish in DMEM media with 10% calf serum. After the cells had covered the bottom of the plate, they were incubated with 0.1% trypsin for 4 min and loose cells were rinsed from the plates. The smooth muscle cells were then passaged in 1:3 ratio. Cells between 1 and 10th passages were used for these studies.
Cell identification. The identity of the cells was confirmed by morphologic criteria with phase-contrast microscopy. In addition, all the cells were examined for the presence of Factor VIII using indirect immunofluorescence with a monospecific bovine Factor VIII antibody, a gift of J. Brown, University of California, San Diego (7). Angiotensinconverting enzyme activity in cultured cells was determined using a radioassay (Ventrex, Portland, ME). The endothelial cells from the retinal capillary and the aorta were positive for Factor VIII and angiotensin-converting enzyme activity, whereas pericytes and smooth muscle cells were not. By using these biochemical and morphological tests, the cultures were determined to be free of contaminating cells.
Autoradiography. Cells were seeded to 50% of confluency and maintained for 24 h in DMEM media with 0.5% bovine serum. Hormones were added for 20 h, followed by [3H]thymidine (New England Nuclear) for 24 h. The procedure for fixing and developing have been described (15) .
Binding studies. '251I-insulin, '251-IGF, or '251I-MSA binding studies were performed on cells attached to 35-mm six-well plates (-50,000 cpm to each well) as described earlier (7, 16 [3H]Thymidine incorporated into DNA. Cells were grown to near confluence at 37°C in six-well cluster plates (Costar). The growth media was replaced with serum-free DMEM medium, pH 7.4, containing 2.5 mg/ml bovine serum albumin and 0.5% of bovine serum for 1-2 d. Insulin, IGF-I, or MSA were added to each well with fresh serum-free DMEM media at the indicated concentrations for 18 h, after which the cells were pulsed with [3H]thymidine, 2 ,Ci/ml, for 30 min at 37°C. The cells were solubilized with 0.1% sodium dodecyl sulfate, and the DNA precipitated with 10% trichloracetic acid at 4°C and counted in a scintillation counter as previously described (15, 16) .
Cell number count. Cells were grown in 12-well cluster dishes (Costar) as discussed above and released from the plate by 0.1 trypsin in PBS. The cell number was determined by Coulter counters in triplicate. (Table I) Conditions for binding are as described in Methods.
Results
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endothelial cells (Fig. 4 A) , but only 1.7-2.5% in the retinal capillary endothelium (Fig. 4 B) (Fig. 5 A), and it was 5.6% in the pericytes (Fig. 5 B) . 1-1.5 X 10'
M MSA displaced 50% of the specifically bound '251-MSA in both types of cells, and in neither type did insulin cause any displacement, even at 10-7 M for the smooth muscle and 10-6
M for the pericytes. Scatchard analysis yielded straight line plots, as illustrated in Fig. 2 threefold (Fig. 6) . Insulin appeared to be more potent than IGF-I or MSA. Some stimulation of DNA synthesis was observed with 3 X 10-9 M, half-maximal at 1 X 1O-8 M, and the maximal effect occurred at 10-7 M. IGF-I stimulated [3H]thymidine incorporation starting at 5 X 10-9 M, halfmaximal stimulation was at 3 X 10-8, and the maximal effect was reached at 5 X 10-8 M. The dose-response curves of IGF-I and insulin were strikingly different in their shape. The IGF dose-response curve occurred over a very narrow range (5 X 10-9 M to 5 X 10-8 M), whereas insulin's range was quite broad (3 X 10-9 M to 2 X 10-7 M). MSA was the least potent of the three hormones for stimulation of DNA synthesis, requiring 5 X 1o-8 M for minimally effective and I0O-M for maximal effect. Addition of maximal effect concentrations of insulin and the IGFs (IGF-I and MSA) resulted in no additional effect, suggesting these hormones are stimulating DNA synthesis through the same pathway (Fig. 7 A) . M with a 6-7-fold increase above basal (Fig. 9 ). IGF-I produced a significant increase in DNA synthesis beginning at 1 X 10-9
M and caused a probable maximum response at 5 X 10-8 M.
MSA was 10-fold less potent than IGF-I or insulin. The maximal level of stimulation was probably the same for both IGF-I and insulin since the addition of 5 X 10'8 M IGF-I and 1 X 10-6 M insulin was no more effective than either the IGF-I or the insulin alone (Fig. 7 B) . Similar to the retinal endothelial cells, the dose-response curve of insulin differed from that of the IGFs by extending over a very broad range of concentration (10-10 M_10-7 M). Again, with the combination of suboptimal concentrations of insulin (1.6 X 108 M)
and IGF-I (5 X 10-9 M), an additive response was observed (Fig. 7 B) . In addition to stimulation of DNA synthesis, insulin at 1 X 10-6 M increased the cell number of the penicytes by 1.9-fold above basal conditions (Table IV) , and 10% calf serum increased the number of penicytes by 3.5-fold. Aortic smooth muscle cells (in the presence of 0.5% serum) responded to insulin, IGF-I, and MSA to the same maximum level (Fig. 10) (Fig. 1 0) (Table II) . The data presented have documented specific receptors for IGF-I and MSA (an IGF-II) on bovine retinal capillary pericytes and endothelial cells, and on aortic endothelial and smooth muscle cells. All four cell types possess IGF-I and II receptors that are similar to those reported previously in other cells with respect to affinity and numbers (19, 20) . Both insulin and MSA are able to bind to the IGF-I receptor with an affinity (Fig. 9 ). This differential responsiveness to IGFs is consistent with our previous study in which we showed that these cells had a similar response to insulin (7). The narrow doseresponse curves of the IGF-I suggests that its growth-promoting effect is mediated only via its own receptors (Fig. 6 ). In pericytes, insulin can bind both to its own receptors at high affinity (7) and to IGF-I receptors at low affinity (Fig. 3 B) . Thus, insulin may stimulate growth in the pericytes through both receptors, and this may account for the broad dose- The finding of differential responsiveness to insulin and IGFs may be important in the histopathological differences observed in diabetic retinopathy and peripheral macroangiopathy. Both of these vascular complications of diabetes have in common the feature of cellular proliferation as a part of the pathologic process, although different cells are involved: endothelial cells proliferating in retinopathy (2) and smooth muscle cells in peripheral macroangiopathy (22) . Our data would suggest that elevations of insulin and IGF-I which may occur during intensive insulin treatment (23, 24) For macroangiopathy, no endothelial cell proliferation is observed, although arterial endothelial cells are exposed to similar levels of insulin and IGF-I, possibly because the proliferation of the arterial endothelial cells is controlled differently, as documented by their unresponsiveness to insulin and IGFs. However, arterial smooth muscle cells are responsive to both insulin and IGFs, and their effects are additive at near physiological concentrations. Thus, hyperinsulinemia in combination with an elevation in IGF-I could accelerate the proliferation of vascular smooth muscle cells and thus aggravate the ongoing process of atherosclerosis. Clinically, peripheral vascular complications occur more frequently in non-insulindependent diabetic patients who often have more hyperinsulinema (26, 27) , and hyperinsulinema also has been shown to correlate with the occurrence of atherosclerosis (27, 28 atherosclerosis. These data suggest that insulin and IGFs may have a role in the development of diabetic vascular complications.
